FB
Skip to content
Search:
Search
CLIA RegulationsASCLSASCLS PACCareers
Facebook page opens in new windowX page opens in new windowInstagram page opens in new windowLinkedin page opens in new windowYouTube page opens in new window
Labvocate
The premier advocacy organization for medical laboratory professionals
Labvocate
  • Issues
    • Clinical Laboratory Workforce
    • Regulation
    • Clinical Laboratory Reimbursement
  • Action
    • Why We Labvocate
    • Labvocate Ambassadors
    • Labvocate Action Center
  • Prepare
    • Appointments with Congress
  • About
    • What is a Labvocate?
  • Issues
    • Clinical Laboratory Workforce
    • Regulation
    • Clinical Laboratory Reimbursement
  • Action
    • Why We Labvocate
    • Labvocate Ambassadors
    • Labvocate Action Center
  • Prepare
    • Appointments with Congress
  • About
    • What is a Labvocate?

May 2024

You are here:
  1. Home
  2. 2024
  3. May

Food and Drug Administration

FDA Final Rule on Regulation of Laboratory Developed Tests (LDTs)

The LabvocateBy ASCLSMay 17, 2024

On May 6, 2024, the Food and Drug Administration (FDA) published the final rule defining how the agency will be changing enforcement discretion on LDTs. The rule is substantially changed from the preliminary rule published late last year. The changes are directly responsive to many of the concerns raised by ASCLS and other laboratory groups, which universally told FDA…

Labvocate
The American Society for Clinical Laboratory Science
P.O. Box 92 | Dundee, MI 48131
Ph. 301.478.6379 | Email ascls@ascls.org

© ASCLS 2026

Go to Top